Chapter 21. Representative Cancers, Treatment and Market

  1. Sotiris Missailidis
  1. Teni Boulikas and
  2. Nassos Alevizopoulos

Published Online: 7 NOV 2008

DOI: 10.1002/9780470697047.ch21

Anticancer Therapeutics

Anticancer Therapeutics

How to Cite

Boulikas, T. and Alevizopoulos, N. (2008) Representative Cancers, Treatment and Market, in Anticancer Therapeutics (ed S. Missailidis), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470697047.ch21

Editor Information

  1. Department of Chemistry and Analytical Sciences, The Open University, Milton Keynes, UK

Author Information

  1. Regulon Inc. (USA), Afxentiou 7, Alimos, Athens, Greece

Publication History

  1. Published Online: 7 NOV 2008
  2. Published Print: 21 NOV 2008

ISBN Information

Print ISBN: 9780470723036

Online ISBN: 9780470697047



  • small cell (SCLC) and non-small cell (NSCLC) lung cancers;
  • representative cancers;
  • treatment and market;
  • breast cancer - ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS);
  • gastric cancer;
  • combination chemotherapy in cancer treatment;
  • anticancer drugs and pharmaceutical world;
  • cancer pharmacoeconomics;
  • biological marker and disease indication


This chapter contains sections titled:

  • Lung Cancer

  • Breast Cancer

  • Prostate Cancer

  • Colorectal Cancer

  • Ovarian Cancer

  • Pancreatic Cancer

  • Gastric Cancer

  • Combination Chemotherapy

  • The Pharmaceutical World of Anticancer Drugs